Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in January. Here is a list of some of the biggest funding rounds.
OpenEvidence raises $250 million in Series D funding
The Power of One: Redefining Healthcare with an AI-Driven Unified Platform
In a landscape where complexity has long been the norm, the power of one lies not just in unification, but in intelligence and automation.
OpenEvidence provides an AI-powered medical search and decision-support platform that gives doctors real-time, citation-backed answers drawn from peer-reviewed medical literature and clinical guidelines. Its medical search engine is used by more than 10,000 hospitals and medical practices across the U.S.
Its Series D round was co-led by Thrive Capital and DST Global. In total, OpenEvidence has raised nearly $700 million. The funding will be used to “invest heavily in the R&D and compute costs associated with the multi-AI agentic architecture of OpenEvidence,” according to the announcement.
Zarminali Pediatrics lands $110 million in Series A funding
Zarminali Pediatrics was founded in 2024 and provides primary and specialty care for children from birth through adolescence. It offers services like well-child visits and same-day sick care. It provides this care via its 28 clinics across 8 states.
NEMT Partner Guide: Why Payers and Providers Should Choose MediDrive’s TMS
Alan Murray on improving access for medical transportation.
Its Series A round was led by Healthier Capital and included participation from General Catalyst and K2 HealthVentures. In total, it has raised more than $150 million. With the financing, Zarminali will work on rolling out its technology platform, as well as open 15 new clinics, including in markets like Chicago, Milwaukee and Dallas. It will also work on expanding services beyond primary care to include urgent care and specialty services like speech, occupational and behavioral therapy.
Pomelo Care secures $92 million in Series C funding
New York City-based Pomelo Care offers pregnancy, pediatric, midlife and women’s health support. Patients receive virtual 24/7 support through the app and gain access to a dedicated care team and customized care plans. It leverages predictive analytics to help clinicians identify issues early and intervene quickly. The company works with payers and employers, and serves 25 million covered lives through commercial and Medicaid health plan partnerships.
The Series C round was led by Stripes and included participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup and SV Angel. The company is now valued at $1.7 billion and has raised $171.2 million in total. The financing will be used to invest in its clinical teams, technology platform and partnerships with health plans and employers.
Apella raises $80 million
Apella provides an ambient video intelligence platform that gives hospitals real-time operational insight to reduce delays and inefficiencies. By combining ambient AI with EHR data, it helps automates coordination, scheduling and staffing.
The $80 million round was in Series B equity and venture debt. It was led by HighlandX and included participation from Vensana Capital, Casdin Capital, PFM Health Sciences, Upside Partnership, Operator Partners, K2 HealthVentures, OpAmp Capital and Houston Methodist.
Picture: Feodora Chiosea, Getty Images